Fact Check: In her resignation letter, Terrell warned colleagues that she felt Tulane’s leaders 'have chosen to abandon the principles of knowledge, education, and the greater good in pursuit of their own narrow agenda.'

Fact Check: In her resignation letter, Terrell warned colleagues that she felt Tulane’s leaders 'have chosen to abandon the principles of knowledge, education, and the greater good in pursuit of their own narrow agenda.'

Published June 13, 2025
VERDICT
True

# Fact Check: "In her resignation letter, Terrell warned colleagues that she felt Tulane’s leaders 'have chosen to abandon the principles of knowledge...

Fact Check: "In her resignation letter, Terrell warned colleagues that she felt Tulane’s leaders 'have chosen to abandon the principles of knowledge, education, and the greater good in pursuit of their own narrow agenda.'"

What We Know

Kimberly Terrell, a researcher at Tulane University, resigned citing significant concerns regarding censorship from university leadership. In her resignation letter, she explicitly stated that she felt Tulane’s leaders "have chosen to abandon the principles of knowledge, education, and the greater good in pursuit of their own narrow agenda" (AP News, Inside Higher Ed). Terrell's resignation was a response to what she described as a "gag order" imposed on her and her colleagues at the Tulane Environmental Law Clinic, which limited their ability to publicly discuss research related to environmental justice and the impacts of the petrochemical industry in Louisiana (WDSU, NOLA).

Terrell's work focused on racial disparities in the petrochemical workforce and the health impacts of pollution in communities along the Mississippi River, an area often referred to as "Cancer Alley" due to its high levels of industrial pollution (AP News, The Guardian). The university's leadership reportedly expressed concerns that the clinic's advocacy work was jeopardizing funding for university projects, leading to restrictions on public communications (Inside Higher Ed, AP News).

Analysis

The claim that Terrell warned her colleagues about Tulane's leadership abandoning core educational principles is substantiated by multiple credible sources. Each source consistently reports her resignation letter's content, highlighting her concerns about censorship and the prioritization of a narrow agenda over academic freedom (AP News, Inside Higher Ed, WDSU).

The reliability of these sources is generally high, as they include established news organizations like the Associated Press and Inside Higher Ed, which have a history of reporting on academic issues and freedom of speech. However, it is essential to note that the context surrounding Terrell's resignation involves broader political pressures, particularly from Louisiana's Republican Governor Jeff Landry, which adds a layer of complexity to the situation (NOLA, The Guardian).

While some sources mention that university officials denied any wrongdoing or pressure from the governor, Terrell's direct quotes and the consistent reporting across various outlets lend credibility to her claims (Inside Higher Ed, WDSU).

Conclusion

The claim that Kimberly Terrell warned her colleagues about Tulane's leadership abandoning essential principles in her resignation letter is True. The evidence from multiple reliable sources confirms that Terrell expressed serious concerns regarding censorship and the prioritization of a narrow agenda over academic integrity in her resignation letter.

Sources

  1. Tulane scientist resigns citing university censorship of pollution and ...
  2. Tulane Environmentalist Resigns Amid Research 'Gag Order'
  3. Tulane scientist resigns, citing 'gag order' on environmental justice ...
  4. Tulane scientist resigns citing university censorship - WDSU
  5. Tulane University scientist resigns citing environmental ...
  6. Tulane environmental researcher resigns, citing 'gag order ...
  7. Tulane scientist resigns citing university censorship of ...
  8. Tulane Scientist Resigns, Cites Censorship of Pollution and Disparities ...

Have a claim you want to verify? It's 100% Free!

Our AI-powered fact-checker analyzes claims against thousands of reliable sources and provides evidence-based verdicts in seconds. Completely free with no registration required.

💡 Try:
"Coffee helps you live longer"
100% Free
No Registration
Instant Results

Comments

Leave a comment

Loading comments...

More Fact Checks to Explore

Discover similar claims and stay informed with these related fact-checks

Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check:  drug widely used to treat nerve pain has been linked with dementia and cognitive impairment.
A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). 
Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. 
The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term.
Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. 
While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients.
Source: Regional Anesthesia & Pain Medicine (2025).
Partially True
🎯 Similar

Fact Check: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Detailed fact-check analysis of: drug widely used to treat nerve pain has been linked with dementia and cognitive impairment. A new study analyzing over 26,000 patient records has found a significant link between long-term gabapentin use and increased risk of both dementia and mild cognitive impairment (MCI). Patients with six or more prescriptions were 29% more likely to be diagnosed with dementia and 85% more likely to develop MCI within a decade. The risk was even greater among adults aged 35 to 49, prompting researchers to urge physicians to monitor cognitive health in patients using the drug long-term. Gabapentin has grown in popularity as a less addictive alternative to opioids. However, its mechanism—dampening communication between neurons—may also disrupt critical brain connections, potentially contributing to cognitive decline. While past research has been inconclusive, this new study’s large sample size offers more weight to the growing concerns. Researchers stress the importance of further investigation to determine whether gabapentin plays a causal role in dementia development or simply correlates with other risk factors in chronic pain patients. Source: Regional Anesthesia & Pain Medicine (2025).

Aug 15, 2025
Read more →
Fact Check: In her resignation letter, Terrell warned colleagues that she felt Tulane’s leaders 'have chosen to abandon the principles of knowledge, education, and the greater good in pursuit of their own narrow agenda.' | TruthOrFake Blog